Nigeria’s pharmaceutical companies are ramping up investments and expanding operations to tap growing local opportunities.

This summary of recent health news includes U.S. Senator Bernie Sanders advocating for cheaper Ozempic, new findings on ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

GSK, Roche/Genentech, Takeda, Sanofi, and AbbVie. A study has found a higher risk of suicidal thoughts in users of Novo Nordisk's GLP-1 agonist-based drugs for diabetes and obesity, even though ...

Regeneron and GlaxoSmithKline have joined forces to generate genetic sequence data from the 500,000 volunteers in the UK’s Biobank database. The companies hope the initiative will give insights ...

New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

GlaxoSmithKline Pharmaceuticals Ltd. engages ... dermatology, gynecology, diabetes, cardiovascular disease and respiratory diseases. The company also offers a range of vaccines, for the prevention ...

The type 2 diabetes drug metformin helped slow aging across multiple organs, including the brain, kidneys, and the skin, a ...

British drugmaker GSK said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

Share on Pinterest A new study found that certain diabetes medications could help lower the risk of neurodegenerative diseases. FG Trade/Getty Images A team of scientists in Korea recently ...